PENTA-TRIAZOLAM TABLETS .125 MG
TRIAZOLAM : .125 MG · DIN 02232553 · PENTAPHARM LTD.
Health Canada status: CANCELLED (UNRETURNED ANNUAL)
What is PENTA-TRIAZOLAM TABLETS?
PENTA-TRIAZOLAM TABLETS .125 MG contains TRIAZOLAM : .125 MG. It is listed in the Health Canada Drug Product Database under DIN 02232553, held by PENTAPHARM LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled (unreturned annual), status dated 05-Apr-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02232553 |
|---|---|
| Brand name | PENTA-TRIAZOLAM TABLETS |
| Generic / active ingredient | TRIAZOLAM : .125 MG |
| Manufacturer | PENTAPHARM LTD. |
| Strength | .125 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| ATC code | N05CD05 TRIAZOLAM |
| AHFS class | 28:24.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED (UNRETURNED ANNUAL) |
| Status date | 05-Apr-2018 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02232553 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2232553 |
| Brand name | PENTA-TRIAZOLAM TABLETS |
| Active ingredient / INN | TRIAZOLAM : .125 MG |
| ATC code | N05CD05 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05 |
| AHFS class | 28:24.08 |
| Health Canada schedule | TARGETED SUBSTANCES (CDSA IV) |
| Biosimilar biologic | No |
| Market authorization holder | PENTAPHARM LTD. |
Which pack is which?
| Strength on the label | .125 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code N05CD05 TRIAZOLAM. 1 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TRIAZOLAM | 0.25 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00808571 |
| ALTI-TRIAZOLAM TAB 0.125MG | .125 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 00614351 |
| ALTI-TRIAZOLAM TAB 0.25MG | .25 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 00614378 |
| HALCION | 0.125 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00512559 |
| HALCION | 0.25 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00443158 |
| MYLAN-TRIAZOLAM | 0.125 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 01995227 |
| MYLAN-TRIAZOLAM | 0.25 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 01913506 |
| NOVO-TRIOLAM TAB 0.125MG | .125 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00872423 |
| NOVO-TRIOLAM TAB 0.25MG | .25 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00872431 |
| PENTA-TRIAZOLAM TABLETS | .25 MG | TABLET | PENTAPHARM LTD. | CANCELLED (UNRETURNED ANNUAL) | DIN 02232554 |
Who else supplies TRIAZOLAM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRIAZOLAM appears in 11 registered pack listings across 5 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does TRIAZOLAM cost around the world?
TRIAZOLAM is listed on 5 national price registers Nexara tracks, across 18 pack listings published on 5 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 2 | 11 | 03 Sep 2026 |
| South Africa | single exit price | 2 | 3 | 01 Sep 2026 |
| Luxembourg | reimbursement | 2 | 2 | 05 Sep 2026 |
| Austria | KVP (Kassenverkaufspreis) | 1 | 1 | 03 Sep 2026 |
| Spain | PVP con IVA (public price) | 1 | 1 | 05 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled (unreturned annual) in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.